Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer-Reference-Cited by-同舟云学术

Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer

Published:2024-07-19 Issue: Volume: Page:
ISSN:1085-9195
Container-title:Cell Biochemistry and Biophysics
language:en
Short-container-title:Cell Biochem Biophys

Author:

Jafari Seyed Hamed,Lajevardi Zahra Sadat,Zamani Fard Mohammad Masoud,Jafari Ameneh,Naghavi Soroush,Ravaei Fatemeh,Taghavi Seyed Pouya,Mosadeghi Kimia,Zarepour Fatemeh,Mahjoubin-Tehran Maryam,Rahimian Neda,Mirzaei Hamed

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12013-024-01437-z.pdf

Reference229 articles.

1. Raimondi, S., Maisonneuve, P., & Lowenfels, A. B. (2009). Epidemiology of pancreatic cancer: an overview. Nature Reviews Gastroenterology & Hepatology, 6(12), 699–708.

2. Klein, A. P., Brune, K. A., Petersen, G. M., Goggins, M., Tersmette, A. C., & Offerhaus, G. J., et al. (2004). Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Researchearch, 64(7), 2634–2638.

3. Amundadottir, L., Kraft, P., Stolzenberg-Solomon, R. Z., Fuchs, C. S., Petersen, G. M., & Arslan, A. A., et al. (2009). Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nature Genetics, 41(9), 986–990.

4. Wolpin, B. M., Chan, A. T., Hartge, P., Chanock, S. J., Kraft, P., & Hunter, D. J., et al. (2009). ABO blood group and the risk of pancreatic cancer. Journal of the National Cancer Institute, 101(6), 424–431.

5. Li, D., Yeung, S. C., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009). Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology., 137(2), 482–488.